JACKSONVILLE, Fla., Oct. 7, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson*, a global leader in eye health, announced new data on the ACUVUE OASYS MAX 1-Day for ASTIGMATISM ...
Recognized for innovative, immersive, and scalable ethics and compliance training, LRN empowers organizations worldwide to build principled cultures and drive measurable outcomes. LRN Corporation, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback